Jia-Feng Wu1, Chia-Huei Lee2, Huey-Ling Chen1, Yen-Hsuan Ni1, Hong-Yuan Hsu1, Jinn-Chyuan Sheu3, Daw-Jen Tsuei1, Mei-Hwei Chang4. 1. Department of Pediatrics, National Taiwan University Hospital, No. 7, Chung-Shan S. Road, Taipei, 100, Taiwan. 2. National Institute of Cancer Research, National Health Research Institutes, Zhunan, Taiwan. 3. Department of Medical Research and Graduate Institute of Chinese Medical Science, China Medical University, Taichung, Taiwan. 4. Department of Pediatrics, National Taiwan University Hospital, No. 7, Chung-Shan S. Road, Taipei, 100, Taiwan. changmh@ntu.edu.tw.
Abstract
PURPOSE: Hepatoblastoma is a rare childhood liver malignancy with limited relevant cytogenetic data. This study aimed to discover common genomic copy-number variations (CNVs) in subjects with hepatobalstoma and its relevance to the clinical course. METHODS: Gene copy-number was systemically rated by high-resolution comparative genomic hybridization (CGH) DNA oligonucleotide microarray. The study group consisted of 12 children (7 males and 5 females) with hepatoblastoma and another 20 healthy individuals (10 males and 10 females) as controls. The influence of recurrent CNVs on clinical outcomes was analyzed. RESULTS: Four highly recurrent CNVs were identified in these 12 hepatoblastoma children after comparison with controls, including a gain on 1p13.3 (n = 3, 25%) and losses on 5p15.33 (n = 4, 33.3%), 16q12.2 (n = 4, 33.3%), and 19q13.42 (n = 3, 25%). The most prevalent sites of genomic deletion were 5p15.33 and 16q12.2. Zinc finger, DHHC-type containing 11 (ZDHHC11) and DHHC-type containing 11B (ZDHHC11B) were mapped to 5p15.33, which was associated with a lower rate of survival with native liver (p = 0.03). The carboxylesterase 4-like (CES4) gene that mapped to 16q12.2 was associated with smaller tumor size at presentation. CONCLUSIONS: Deletions of 5p15.33 (33.3%) and 16q12.2 (33.3%) are the most frequent hepatoblastoma-related events in our patient group with 5p15.33 microdeletion as a potential biomarker for the fate of survival with native liver.
PURPOSE:Hepatoblastoma is a rare childhood liver malignancy with limited relevant cytogenetic data. This study aimed to discover common genomic copy-number variations (CNVs) in subjects with hepatobalstoma and its relevance to the clinical course. METHODS: Gene copy-number was systemically rated by high-resolution comparative genomic hybridization (CGH) DNA oligonucleotide microarray. The study group consisted of 12 children (7 males and 5 females) with hepatoblastoma and another 20 healthy individuals (10 males and 10 females) as controls. The influence of recurrent CNVs on clinical outcomes was analyzed. RESULTS: Four highly recurrent CNVs were identified in these 12 hepatoblastomachildren after comparison with controls, including a gain on 1p13.3 (n = 3, 25%) and losses on 5p15.33 (n = 4, 33.3%), 16q12.2 (n = 4, 33.3%), and 19q13.42 (n = 3, 25%). The most prevalent sites of genomic deletion were 5p15.33 and 16q12.2. Zinc finger, DHHC-type containing 11 (ZDHHC11) and DHHC-type containing 11B (ZDHHC11B) were mapped to 5p15.33, which was associated with a lower rate of survival with native liver (p = 0.03). The carboxylesterase 4-like (CES4) gene that mapped to 16q12.2 was associated with smaller tumor size at presentation. CONCLUSIONS: Deletions of 5p15.33 (33.3%) and 16q12.2 (33.3%) are the most frequent hepatoblastoma-related events in our patient group with 5p15.33 microdeletion as a potential biomarker for the fate of survival with native liver.
Authors: J Pritchard; J Brown; E Shafford; G Perilongo; P Brock; C Dicks-Mireaux; J Keeling; A Phillips; A Vos; J Plaschkes Journal: J Clin Oncol Date: 2000-11-15 Impact factor: 44.544
Authors: Eva Stejskalová; Josef Malis; Jirí Snajdauf; Karel Pýcha; Helena Urbánková; Viera Bajciová; Jan Starý; Roman Kodet; Marie Jarosová Journal: Cancer Genet Cytogenet Date: 2009-10-15
Authors: Craig E Wheelock; Bryn M Phillips; Brian S Anderson; Jeff L Miller; Mike J Miller; Bruce D Hammock Journal: Rev Environ Contam Toxicol Date: 2008 Impact factor: 7.563